Nope [Two-Stage / GS Designs]

posted by nobody – 2017-11-14 09:11 (2720 d 09:33 ago) – Posting: # 17978
Views: 9,983

IANAL, but I think what San-Diego-man is proposing is to calculate BE-outcome (pass/fail) after stage 1 and compare it to BE-outcome after the (unnecessary) second stage for, let's say, 1 gazillion of studies and see if there is a meaningful difference.

Isn't this a special example of the more general "forced BE" theme in one-stage designs?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
17 visitors (0 registered, 17 guests [including 3 identified bots]).
Forum time: 19:45 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5